HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura A VanBlargan Selected Research

Laura A VanBlargan Research Topics

Disease

20Infections
02/2022 - 01/2013
11COVID-19
03/2022 - 10/2020
3Weight Loss (Weight Reduction)
02/2022 - 08/2021
2Breakthrough Infections
02/2022 - 08/2021
2Pneumonia (Pneumonitis)
02/2022 - 08/2021
2Human Influenza (Influenza)
01/2022 - 12/2021
2Zoonoses
01/2022 - 12/2021
2Dengue (Dengue Fever)
11/2021 - 01/2013
1Vesicular Stomatitis
01/2022
1Immunologic Deficiency Syndromes
01/2022
1Primary Immunodeficiency Diseases
01/2022
1Adenocarcinoma of Lung
01/2021
1Inflammation (Inflammations)
10/2020
1Encephalitis (Encephalitis, Rasmussen)
12/2018
1Flavivirus Infections
12/2018

Drug/Important Bio-Agent (IBA)

11VaccinesIBA
02/2022 - 01/2013
8AntibodiesIBA
03/2022 - 12/2016
6Neutralizing AntibodiesIBA
03/2022 - 01/2013
6Monoclonal AntibodiesIBA
03/2022 - 12/2016
5Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2018
4mRNA VaccinesIBA
02/2022 - 12/2018
4EpitopesIBA
01/2022 - 01/2021
2Messenger RNA (mRNA)IBA
02/2022 - 01/2022
2Antiviral Agents (Antivirals)IBA
01/2022 - 12/2016
2Influenza Vaccines (Influenza Vaccine)FDA Link
01/2022 - 12/2021
1ADM03820IBA
03/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1AntigensIBA
01/2022
1Ad26COVS1IBA
01/2022
12019-nCoV Vaccine mRNA-1273IBA
01/2022
1Combined VaccinesIBA
11/2021
1Sulfates (Sulfates, Inorganic)IBA
01/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1Broadly Neutralizing AntibodiesIBA
01/2021
1NucleoproteinsIBA
10/2020
1Immunoglobulin A (IgA)IBA
10/2020
1Viral RNAIBA
10/2020
1InterferonsIBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1RNA CapsIBA
01/2018
1Immune Sera (Antisera)IBA
09/2015

Therapy/Procedure

5Therapeutics
03/2022 - 08/2015
1Intranasal Administration
10/2020